MZB1
Marginal zone B- and B1-cell-specific protein
Also known as: HSPC190, MEDA-7, MGC29506, MZB1_HUMAN, PACAP, pERp1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WU39
- Gene
- MZB1
- Ensembl
- ENSG00000170476
- Chromosome
- 5
- Canonical length
- 189 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Involved in positive regulation of cell population proliferation. Located in cytoplasm and extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
189 residues, UniProt reviewed canonical sequence.
>Q8WU39|MZB1
1 MRLSLPLLLL LLGAWAIPGG LGDRAPLTAT APQLDDEEMY SAHMPAHLRC DACRAVAYQM
61 WQNLAKAETK LHTSNSGGRR ELSELVYTDV LDRSCSRNWQ DYGVREVDQV KRLTGPGLSE
121 GPEPSISVMV TGGPWPTRLS RTCLHYLGEF GEDQIYEAHQ QGRGALEALL CGGPQGACSE
181 KVSATREELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MZB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 215 nTPM
Expression across tissuesHPA
Tissue
- spleen: 215 nTPM
- thymus: 137 nTPM
- lymph node: 116 nTPM
- tonsil: 110 nTPM
- duodenum: 85 nTPM
- appendix: 82 nTPM
Single-cell type
- plasma cells: 4,017 nCPM
- pdcs: 466 nCPM
- gastric chief cells: 159 nCPM
- thymocytes: 154 nCPM
- foveolar cells: 94 nCPM
- parietal cells: 69 nCPM
Immune cell
- plasmacytoid DC: 571 nTPM
- memory B-cell: 161 nTPM
- naive B-cell: 76 nTPM
- total PBMC: 26 nTPM
- neutrophil: 3.1 nTPM
- MAIT T-cell: 3 nTPM
Brain region
- cerebral cortex: 1 nTPM
- spinal cord: 0.7 nTPM
- white matter: 0.5 nTPM
- choroid plexus: 0.4 nTPM
- thalamus: 0.2 nTPM
- basal ganglia: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.49
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- integrin activation
- positive regulation of cell population proliferation
- positive regulation of immunoglobulin production
- regulation of B cell proliferation
- regulation of cell population proliferation
- regulation of insulin receptor signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Domain of unknown function DUF3456
- TLR4 regulator and MIR-interacting MSAP
- Marginal zone B- and B1-cell-specific protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MZB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MZB1 as an antibody target. Whether an autoantibody or antibody against MZB1 could matter depends on whether native MZB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MZB1 is annotated as secreted, so native MZB1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MZB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...